Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Schizophrenia

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Minimum Sample Size Requirements for Machine Learning: A Study on Diabetic Neuropathy Prediction.

Studies in health technology and informatics·2026

Same author

Serum fibroblast growth factor-2 and fibroblast growth factor-9 levels in bipolar disorder: Potential biomarkers for mood episodes.

Psychiatry research·2026

Same author

Serum zonulin, brain-derived neurotrophic factor, and oxidative stress levels in individuals using paper (A4) impregnated with synthetic cannabinoids.

Frontiers in psychiatry·2025

Same author

Gut Microbiota and Short-Chain Fatty Acid Profiles in Facioscapulohumeral Dystrophy: Associations with Epigenetic Alterations.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2025

Same author

In Vivo Clinical Evaluation of Human Intestinal Tissue Viability Using a Spectroscopic Method.

The Journal of surgical research·2025

Same author

Using Large Language Models for Data Cleaning: An Evaluation of ChatGPT-4o's Performance.

Studies in health technology and informatics·2025

Search research articles

Related Experiment Video

Updated: Oct 5, 2025

Development of a Virtual Reality Assessment of Everyday Living Skills

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

A Self-Management App for Patients with Schizophrenia: A Pilot Study.

Buket Cinemre¹, Mahmut Gulerce², Kemal Hakan Gulkesen²

¹Department of Psychiatry, Faculty of Medicine, Akdeniz University, Antalya, Turkey.

Studies in Health Technology and Informatics

|January 22, 2022

Summary

A mobile app improved medication adherence and daily life skills for schizophrenia patients. This digital tool shows promise in supporting self-management and enhancing patient outcomes in mental healthcare.

Keywords:

Schizophrenia mobile applications reminder systems smartphone

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Related Experiment Videos

Last Updated: Oct 5, 2025

Development of a Virtual Reality Assessment of Everyday Living Skills

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Area of Science:

Psychiatry
Digital Health
Mental Healthcare Technology

Background:

Schizophrenia management requires consistent medication adherence and daily activity engagement.
Self-management tools can empower patients but require effective design and usability.
Mobile applications offer a scalable platform for delivering self-management support.

Purpose of the Study:

To evaluate the efficacy of a self-management mobile application for patients diagnosed with schizophrenia.
To assess the impact of the app on medication adherence and daily life skills.
To determine the feasibility and patient engagement with a digital self-management tool.

Main Methods:

A prospective study involving twelve schizophrenia patients using a custom-designed mobile app for one month.
The app facilitated medication reminders, activity tracking, and daily record-keeping.
Psychiatric assessments, including the PANSS and FROGS scales, were administered pre- and post-intervention.

Main Results:

Significant reductions in Positive and Negative Syndrome Scale (PANSS) scores (p=0.040) were observed.
Improvements in Functional Ratings for Granting Occupations in Schizophrenia (FROGS) daily life skills scores were statistically significant (p=0.012).
Patients demonstrated consistent engagement with the app, with high numbers of daily reminders and data entries.

Conclusions:

The self-management mobile app demonstrated a positive impact on clinical symptoms and daily functioning in schizophrenia patients.
Mobile health interventions can be effective tools for supporting schizophrenia self-management and improving patient outcomes.
Further research with larger cohorts is warranted to confirm these findings and explore long-term effects.